VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $159 | -69.7% | 1,275,215 | -75.0% | 0.02% | -75.4% |
| Q4 2022 | $525 | -99.9% | 5,095,354 | -2.4% | 0.06% | -38.1% |
| Q3 2022 | $794,000 | +556.2% | 5,222,292 | +3686.0% | 0.10% | +483.3% |
| Q2 2022 | $121,000 | +31.5% | 137,938 | +86.5% | 0.02% | +50.0% |
| Q1 2022 | $92,000 | +4.5% | 73,969 | +131.3% | 0.01% | +33.3% |
| Q3 2021 | $88,000 | – | 31,984 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|